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Integrated solid-state NMR and molecular
dynamics modeling determines membrane
insertion of human β-defensin analog
Xue Kang
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Human β-defensins (hBD) play central roles in antimicrobial activities against various
microorganisms and in immune-regulation. These peptides perturb phospholipid membranes
for function, but it is not well understood how defensins approach, insert and ﬁnally disrupt
membranes on the molecular level. Here we show that hBD-3 analogs interact with lipid
bilayers through a conserved surface that is formed by two adjacent loops in the solution
structure. By integrating a collection of 13C, 1H and 31P solid-state NMR methods with longterm molecular dynamic simulations, we reveal that membrane-binding rigidiﬁes the peptide,
enhances structural polymorphism, and promotes β-strand conformation. The peptide colocalizes with negatively charged lipids, conﬁnes the headgroup motion, and deforms membrane
into smaller, ellipsoidal vesicles. This study designates the residue-speciﬁc, membrane-bound
topology of hBD-3 analogs, serves as the basis for further elucidating the function-relevant
structure and dynamics of other defensins, and facilitates the development of defensinmimetic antibiotics, antifungals, and anti-inﬂammatories.
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uman β-defensins (hBD) are a family of antimicrobial
peptides widely distributed in leukocytes and epithelial
cells. These small cationic peptides (3–5 kDa) form the
ﬁrst line of immune defense against pathogenic infections by a
broad spectrum of microorganisms, including Gram-positive and
-negative bacteria, yeast, and encapsulated viruses1–3. Defensins
also show chemotactic activity for monocytes, T cells and
immature dendritic cells, reduce tissue damages by antimicrobial
effectors4–6, and inhibit tumor cell migration7,8. These biological
functions, in particular, the microbicidal activity of defensins and
other relevant antimicrobial peptides correlate with their capability of disrupting and permeabilizing membranes and causing
membrane leakage to the invading microbes9–13. Efforts have
been devoted to developing and engineering defensin-mimetic
compounds as novel therapeutic agents against drug-resistant
strains of bacteria and fungi, such as Candida albicans and Staphylococcus aureus14,15, however, a major hurdle here is our
limited understanding of the membrane-associated functional
structure of defensins.
In humans, six α-defensins (~30 residues) and 28 types of βdefensins (33–47 residues) have been identiﬁed16,17. Both α- and
β-defensins have six cysteine residues, but adopt distinct patterns
in pairing and disulﬁde-bond formation. The solution or crystallographic structures of ﬁve β-defensins, including hBD-1, -2,
-3, -4, and -6 have been determined18–24, which feature a triplestranded β-sheet fold as stabilized by three disulﬁde bonds. These
peptides have a net charge density ranging from + 4 to + 11, and
hBD-3, the focus of this study, is the most cationic peptide in this
family, therefore, stronger interactions with the negatively
charged bacterial membranes are expected25. Recently, the
reduced analogs have also been shown to have comparable, if not
greater, antimicrobial activity as the wild-type hBDs26. The
analog adopts a structure that is less constrained than that of
wild-type hBD-3, and retains the capability of disrupting the
outer membrane of bacteria27–29. However, how these peptides
interact with phospholipid membranes remain elusive and a
central contribution of this study is to establish a high-resolution,
residue-speciﬁc view of the insertion topology of hBD-3 analogs
in lipid bilayers.
Three non-speciﬁc mechanisms of membrane-disruption have
previously been proposed depending on the depth of insertion of
the peptides. If only surface-coating occurs, the peptides will form
a carpet outside the membrane and gradually dissolve the
membrane like detergent30. When partially immersed in the
membrane, the peptide may reside within one leaﬂet of the lipid
bilayers and interrupt membrane integrity. If the peptide fully
penetrates through the membrane, membrane-spanning pores
can be formed as described in the toroidal and barrel-stave
models, which are stabilized and supported by the oligomerization of peptides31–34.
Here, we integrate 2D 13C–13C, 13C–1H, and 31P–31P correlated solid-state NMR (ssNMR) spectroscopy with molecular
dynamics (MD) simulation to provide the ﬁrst site-speciﬁc evidence on the structure and dynamics of hBD-3 analogs in POPC/
POPG lipid bilayers. Without the three disulﬁde bonds, the
analog can still bind lipid bilayers using a conserved surface and
efﬁciently break down the vesicles, which sheds light onto the
membrane-disruption mechanism of this antimicrobial peptide.
Membrane-binding enhances the structural polymorphism of
hBD-3 analog, resulting in three conformers with distinct insertion patterns. The major conformer has a β-strand-dominant
backbone conformation similar to that in solution, indicating an
insigniﬁcant role of large-scale restructuring for function. This
study provides novel insights into the functional structure of
human β-defensins and membrane-disruption mechanism, which
2

facilitates the development of defensin mimetics to address the
increasing threat of antimicrobial resistance.
Results
hBD-3 analog is polymorphic in water and lipid bilayers. To
achieve site-speciﬁc resolution for NMR characterization, we
synthesized the hBD-3 analog, a 45-residue peptide, using two
isotope-labeling schemes (Fig. 1a). In total, nine 13C, 15N-labeled
residues are included to cover both the N- and C-terminal halves
of peptide sequence, as well as the different structural domains.
Peptide 1 (VALIG) contains labels at V13, A19, L21, I30, and
G37, while Peptide 2 (IVLG) has labeled residues of I3, V20, L24,
and G31. All the cysteine residues are in the reduced form, which
deﬁnes the analog state. Because hBD-3 is rich in cationic residues (13 Arg and Lys) that confer bactericidal activity35, both
peptides were reconstituted into POPC/POPG lipid bilayers that
mimic the negatively charged state of bacterial membranes.
Figure 1b shows the representative 1D 13C spectra of hBD-3
analogs in POPC/POPG bilayers. With 65–70 wt% hydration, the
hBD-3 analog exists in three major states with decreasing
mobility: dissolved in solution, loosely associated with the
membrane surface, and deeply inserted into the lipid bilayers.
The highly mobile hBD-3 analogs dissolved in the aqueous phase
is detected through the J-coupling-based refocused Insensitive
Nuclei Enhanced by Polarization Transfer (INEPT)
technique36,37. 13C direct polarization (DP) with a short recycle
delay preferentially selects the relatively mobile components38,39,
with contributions from partially dissolved or loosely bound
peptides, while 1H-13C cross-polarization (CP) detects the
peptides rigidiﬁed by their insertion in lipid bilayers. At 298 K,
the well-inserted peptides are relatively rare as evidenced by the
eight times stronger peptide signals in DP than in CP spectrum.
The peptide peaks at 40–60 ppm region shows identical 13C
chemical shifts in INEPT and DP spectrum, but change slightly
from those in CP spectrum. Taken together, the hBD-3 analog
undergoes minor structural changes upon binding to the
membrane, whereas there is little difference between the dissolved
state and the state with loose attachment to the membrane. As
most peptides remain relatively mobile at high temperature and
CP cannot provide sufﬁcient sensitivity for two-dimensional (2D)
experiments, a moderately lower temperature 269 K is used to
overcome the sensitivity barrier for detecting membrane-bound
peptides and to simultaneously retain the liquid-crystalline phase
of the membrane as demonstrated by the sharp 1H peaks of lipid
acyl chains (Supplementary Fig. 1)40. The 2D 13C–13C correlation
spectra provide atom-speciﬁc resolution of hBD-3 analog in both
mobile and membrane-bound states (Fig. 1c; Supplementary
Fig. 2), and all the 13C chemical shifts are documented in
Supplementary Table 1.
The structure of hBD-3 analog is highly polymorphic when
bound to phospholipid membranes. The dynamic peptides in
water exhibit relatively sharp linewidths of 1–1.5 ppm for aliphatic
carbons, because the conformational heterogeneity is averaged out
by rapid motions (Fig. 1c). Most residues show a single set of
chemical shifts, while residues I3, A19, V20, and I30 have an
additional, minor set of peaks, indicating the presence of a less
populated state in addition to the major conformer. In contrast,
the rigid, membrane-bound peptides have substantially broader
linewidths and more pronounced peak multiplicity. For example,
three well-resolved Cα-Cβ cross peaks have been identiﬁed for I30
at (60, 37 ppm), (59, 41 ppm), and (57, 39 ppm). Similarly, we
have identiﬁed three subtypes for I3, L21, and L24 residues, and
two conformers for the other residues, indicating a highly
polymorphic peptide structure induced by membrane interactions.
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Fig. 1 Isotope-labeling schemes and 13C solid-state NMR spectra of hBD-3 analog. a The 13C, 15N-labeled residues are in red for VALIG peptide, and in blue
for IVLG peptide in both the amino acid sequence and solution monomeric structure of wt-hBD-3 (PDB 1KJ6). b 1D 13C spectra of VALIG peptide in POPC/
POPG bilayers at 269 K and 298 K. From top to the bottom are INEPT, DP, and CP spectra measured at 298 K, and CP spectrum at 269 K. Dashlines
indicate the resolved peptide peaks. c 2D 13C-13C correlation spectra of VALIG with 100-ms DARR mixing. The rigid and mobile components are selected
using 1H–13C CP and 13C DP, respectively. Greek letters indicate carbon sites and superscripts annotate conformers. I30aαβ: carbon α to carbon β cross
peak of subtype-a I30
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Dominant β-strand conformation in lipid bilayers. The hBD-3
analogs are rich in β-strand conformation as revealed by the 13C
backbone chemical shifts that are sensitive to φ and ψ torsion
angles (Fig. 2a)41. The chemical shift differences between the
observed data and random coil values of Cα and CO are used to
identify the secondary structure42. In the mobile phase, the major
conformer of hBD-3 analog is predominantly in β-strand, except
for the N-terminus, which is consistent with the solution-NMR

monomeric structure of hBD-318. The secondary chemical shifts
characterize I3 as α-helical conformation, but suggest V13 as part
of the loop. Consistently, when bound to lipid bilayers, the overall
β-strand conformation is retained (Fig. 2b). Compared with the
aqueous phase, the membrane-bound peptides have a higher
tendency for α-helical conformation at V13 position in its major
conformer, but more pronounced β-strand conformation for the
minor subtype. It should be noted that the presence of membrane
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Fig. 3 Site-speciﬁc depth of insertion of hBD-3 analog in POPC/POPG bilayers. a 2D 13C–1H correlation spectrum of VALIG, with 225-ms 1H spin diffusion
and the representative 1H cross-sections of L21aCα at different 1H mixing times. The water-to-peptide (purple) and lipid-to-peptide (black) 1H polarization
transfer curves of b, well-inserted residues and c, surface-bound residues are shown. The carbon site and the best-ﬁt distances are labeled for each panel.
Error bars are standard deviations that are propagated from signal-to-noise ratios. d I30 is far from both water and lipids. e Summary of distances from
water and lipid acyl chains to the peptide

environment is crucial for the folding of hBD-3 analog as revealed
by circular dichroism (CD) spectra (Supplementary Fig. 3).
Insertion depth is site-speciﬁc and conformer-dependent. Since
hBDs inhibit bacteria by breaching their surface membrane, it is
of high signiﬁcance to determine the site-speciﬁc insertion
topology of these peptides in bacteria-mimetic membranes.
Herein, we conducted a series of 2D 13C-detected 1H spin diffusion experiments that correlate the peptide 13C signals with the
lipid CH2 (1.3 ppm) and water (4.9 ppm) 1H signals, the intensities of which reﬂect the spatial proximity of each residue to the
lipid acyl chain and surface water, respectively (Fig. 3a). With
only a moderate 1H mixing time of 100-225 ms, many
peptide–lipid cross peaks already appeared, conﬁrming the
membrane insertion of hBD-3 analogs. In contrast, if a peptide
only binds membrane surface, the paramyxovirus fusion peptide
in DMPC bilayers for example, no peptide–lipid cross peaks are
observed even at longer mixing times up to 900 ms43,44.
The depth of insertion of hBD-3 analog is residue-speciﬁc,
which is demonstrated by the wide range of semi-quantitative
distances derived by ﬁtting the intensity buildup curves using a
1D lattice model manipulating polarization transfer (Fig. 3b–d)45.
The results are mainly categorized as membrane-inserted (Fig. 3b)
and surface-bound residues (Fig. 3c). Residues G37a, V20a, L24a,
and L24c are found to be well-inserted, with the lipid CH2 signals
reaching plateau rapidly, within 100 ms, but much slower buildup
curves for water intensities (Fig. 3b). Consequently, the lipid-topeptide distance is best ﬁt to 2 Å, whereas the distance from water
to peptide varies from 2 to 6 Å. In contrast, L21a, I3a, I3b, A19,
and L24b are spatially proximal to water (2 Å), but far from lipid
acyl chains (4–10 Å), thus residing on the membrane surface
(Fig. 3c). It is unexpected that no equilibrium could be reached
for I30 even with an extended mixing time of 400 ms, neither for
water nor lipids (Fig. 3d). It suggests that I30 is embedded in the
4

hydrophobic core of the peptide, likely on a peptide–peptide
interface, thus becoming inaccessible to external molecules.
The membrane-bound topology of hBD-3 analog is also found
to be conformation-dependent. As revealed by the NMR-derived
distance map (Fig. 3e), the polymorphic residue L21 has its major
conformer (type-a, L21aα) binding membrane surface and the
minor conformer (type-b, L21b β) inserted in the hydrophobic
core, whereas L24 has the reversed trend. The N-terminus of
hBD-3 is consistently water-proximal, while the C-terminus is
deeply inserted into the bilayers. These NMR data resolved the
site- and conformer-speciﬁc membrane insertion of hBD analogs.

Membrane-bound residues are rigidiﬁed. To probe the peptide
dynamics, we measured the motionally averaged 13C–1H dipolar
coupling of each residue in POPC/G bilayers. With a dipolar
dephasing period, the decline of peptide peak intensity indicates
relatively strong 13C–1H dipolar couplings (Fig. 4a). Most of the
dipolar evolution curves exhibit asymmetric patterns indicative of
intermediate-time scale motion. Only I3 has a near-symmetric
curve and a long T2 relaxation time of 5 ms due to the high
mobility and solvation of the N-terminus (Fig. 4b, c; Supplementary Table 2). The best-ﬁt dipolar coupling constant and
order parameters are listed for each carbon site.
The dynamics of membrane-bound hBD-3 analog is sitedependent. At 269 K, the Cα signals of I3, A19, L21b, and G31
have small order parameters ranging from 0.50 to 0.64, indicating
large-amplitude motions (Fig. 4b, d). On the contrary, larger
order parameters of 0.73–0.82 have been observed for the
backbone carbons of G37, V20, L24a, and L24b (Fig. 4c, d): all
these residues have shown deep insertion (Fig. 3e), which in turn
conﬁnes their motion. At a higher temperature of 298 K, the
order parameters are slightly lower for the membrane-inserted
peptides (0.5–0.8) with V20 and L24 remaining as the most rigid
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residues, but they decrease substantially to 0.3–0.5 for unbounded
peptides (Supplementary Fig. 4, Supplementary Table 2).
Remarkably, the order parameters are consistent with the
corresponding depths of insertion (Figs. 3e, 4d): only those
residues on membrane surface can undergo large-amplitude
motions, while those well-inserted residues are immobilized. Such
high-resolution information is heretofore unavailable and will be
integrated with MD modeling to detail the topology of hBD-3
analog in membranes as described later.
Peptides disrupt membrane morphology and rigidify POPG
lipid. The dynamics, symmetry and phase, and surface curvature
of phospholipid membranes can be closely monitored using 31P
NMR. Adding peptides induces a considerable change in the
static 31P spectral pattern (Fig. 5a), indicative of an altered distribution of lipid headgroup orientation: with hBD-3 analogs, the
membrane should exist in ellipsoid shape instead of spheres, and

this NMR observation echoes the imaging results (Supplementary
Fig. 6). The absence of a sharp, isotropic peak excludes the possibility of isotropic phases, such as micelles and cubic phase46,47.
Hexagonal phase is not present either as the signature inverted
powder pattern is missing48,49.
The rate of phospholipid reorientation along the membrane
surface due to the lateral diffusion is probed using 2D static 31P–
31P exchange spectra. Adding peptides increases the off-diagonal
intensity (Fig. 5b, c; Supplementary Fig. 5), revealing a higher
diffusion coefﬁcient50–52, and subsequently, a higher curvature
and smaller vesicles. Therefore, hBD-3 analog has fragmented
POPC/G membranes into smaller, ellipsoidal vesicles, which
facilitates efﬁcient reorientation of lipids (Fig. 5d).
Given the cationic state of hBDs, electrostatic interactions with
negatively charged lipids may play a central role in stabilizing
peptide–membrane interactions. Magic-angle spinning (MAS)
unambiguously resolves the 31P signals of neutral POPC and
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Fig. 6 MD simulation reveals the insertion pattern of hBD-3 analog in POPC/G bilayers. a The topview and b, sideview of the last structure of hBD-3
analogs (magenta) in POPC/G from Anton Simulation. Water and ions are not shown. POPC and POPG lipids are in yellow and cyan, respectively.
c Zoomed-in view of hBD-3 analog insertion through its loop regions. d Insertion depth matrix for ten peptides in POPC/G lipid bilayers. Residues 18–24 and
36–40 have deep insertion conserved in different peptides. e RMSF of hBD-3 analog binding POPC/G bilayers based on 5.0 µs Anton simulation trajectory

anionic POPG lipids (Fig. 5e) and ﬁtting the spinning sideband
intensities retrieves the 31P chemical shift anisotropy (CSA)
information reﬂective of lipids headgroup dynamics53. With
peptides, the CSA span has decreased for POPC as expected for
enhanced lipid mobility in more dynamic vesicles, but increased
for POPG lipids (Fig. 5e; Supplementary Table 3). This is
attributed to the tight association of POPG and peptide, which
restricts the motion of phosphate headgroups in the negatively
charged lipids.
MD simulation reveals the inserted structure of hBD-3 analog.
To better understand the ssNMR experimental results and correlate them with peptide structure, we run a long-term (5.0 µs)
Anton54 MD simulation on the binding of 18 hBD-3 analogs to a
bilayer formed by 480 POPC/POPG (3:1) lipids. After the peptides approach the membrane initially, during equilibration, 8 out
of 18 peptides detached the membrane surface and partitioned
into the aqueous phase, which explains the NMR sensitivity
barrier for detecting membrane-bound peptides. The last structure of peptide–membrane complex (Fig. 6a, b) and a magniﬁed
view shows the tight membrane association for residues A19,
V20, L21, and G37 (Fig. 6c). These residues are within two loops
spanning from residue 18–24 and 36–40 in solution-NMR
structure, which have deep insertion as revealed by the timeand lipid-averaged map of insertion depth (Fig. 6d). The matrix is
obtained by calculating the average insertion depths of each
residue of individual hBD-3 analog peptide into the top layer of
membranes over the last 4.0 -µs simulation (Supplementary
Fig. 7). These simulation results dovetail with the 1H spin diffusion results and dynamics measurements (Figs. 3, 4), providing
a structural view that generally fulﬁls the NMR-derived restraints.
The root mean-squared ﬂuctuation (RMSF) of the atomic
positions in hBD-3 analog (including both peptide backbone and
sidechains) reveals that only a few hBD units (PROP, PRON, and
PROH) form stable binding with the lipid membranes, with much
smaller RMSF values than the other peptides (Fig. 6e). The lipidbinding of PROG is also partially stable, but with larger-scale
motions (presumably in solution) for the N-terminus, thus
showing higher RMSF. In general, hBD-3 analogs exhibit the
lowest RMSF for the regions of residue 17–22 and 36–39, which
generally match the MD-derived distance map and ssNMRrestrained structural topology.
6

Notably, the analog partially inserts into the POPC/G mixture
lipid bilayers during the self-assembly simulations (Supplementary Fig. 8a). In addition, clustering of POPG lipids to hBD-3 was
observed because of the electrostatic interface between positively
charged hBD-3 and negatively charged POPG lipids. In the selfassembly simulations of the peptide dimer with POPC/POPG
lipids, there are more POPG lipids in the upper leaﬂet than in the
lower leaﬂet, since the peptides stay on the upper leaﬂets. There
are 21 POPG lipids in the upper layer while 15 POPG lipids in
the lower leaﬂet based on trajectories in the last 50 ns MD
simulations. Such observation echoes the preferential colocalization of hBD-3 analogs with POPG lipids (cyan) in the POPC/G
mixture (Fig. 6a)55 and the reduced mobility of these negatively
charged lipids by peptide interactions (Fig. 5e). Therefore, the
binding of hBD-3 promotes lipid clustering of POPG. Currently,
there is no experimental evidence supporting the formation of
lipid nanodomains56, which needs follow-up investigations.
During the simulations of 18 peptides (nine pairs of dimers),
all the dimers dissociated. That is also observed in the selfassembly simulations on hBD-3 dimer in analog forms in the
POPC mixed with POPG lipids (Supplementary Fig. 8a).
However, in a 300-ns MD simulation, it was found that hBD-3
can bind a bilayer containing only POPG lipids in a dimer form
stably, with the binding interface consistent with ssNMR
observations (Supplementary Fig. 8b).
Discussion
To our knowledge, this study presents the ﬁrst high-resolution
investigation that integrates experimental ssNMR results with
long-term MD modeling to reveal the function-relevant structure
and dynamics of hBDs in lipid bilayers and its effects on membrane morphology. Three major ﬁndings are provided. First,
despite the enhanced structural polymorphism, the secondary
structural characteristics of hBD-3 analog are largely retained in
both the solvated phase and membrane-bound state. Therefore,
insigniﬁcant or local ﬂuctuation of the peptide structure is sufﬁcient for accommodating membrane insertion, which differs
from the functional mechanism of many other proteins (e.g.,
fusion proteins) that often require conformational plasticity49,57.
Second, the experimentally measured depth of insertion and
membrane-conﬁned dynamics dovetail with the MD-derived
insertion depth matrix, collectively revealing a membrane-bound
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topology of hBD-3, in which a structural surface that accommodates two adjacent loops is deeply embedded in lipid bilayers.
Third, we ﬁnd that hBDs speciﬁcally interact with and rigidify the
negatively charged POPG, promotes lipid aggregation and
separation, and further deform the membranes to produce
smaller, non-spherical vesicles.
The prevailing, hypothetical models consider the positive
charge (theoretical PI of 10.0), hydrophobic property, and the
secondary structure of the peptide as the determinant of hBD’s
capability of disrupting phospholipid membranes58–60. Our
results suggest a minor role of secondary structure, but demonstrate that the peptide adopts a speciﬁc orientation to insert into
the membrane, with the region containing residues V20, L21, L24,
and G37 being deeply inserted (Fig. 6c). These residues are spatially located at two adjacent loops of solution-NMR wt-hBD-3
structure, and are also highly conserved from mouse to chimpanzee (Supplementary Fig. 9), suggesting that these exposed
hydrophobic residues and this speciﬁc surface binds membrane as
a common feature in the β-defensin family. The potential interactions stabilizing this complex, e.g., hydrogen bonding between
basic residues and membrane phosphate head group or electrostatic contacts, should be further restrained using 31P–13C or 2H–
13C distances61–65.
Although diffusion NMR, dynamic and static light scattering, and native gel-migration analysis have suggested that
hBD-3 form a dimer in solution18, the dimeric structure has
not yet been determined. X-ray has revealed an intermolecular
antiparallel β-sheet formed by the β1-strand of hBD-2 monomer22, while solution-NMR of hBD-3 has proposed strand β-2
as another potential site for dimerization (Supplementary
Fig. 10)18,20. Our 1H spin diffusion data revealed that I30 is
shielded in the hydrophobic core of peptide complex, with slow
1H spin diffusion rate from both lipids and water. Based on the
monomeric structure of wt-hBD-3, the solvent accessible surface area (SASA) calculated by PyMOL is moderate for I30
(30.4 Angstroms2) (Supplementary Table 4), thus this residue
should be at least partially exposed in the monomer. Given the
similar secondary structure between wt-hBD-3 and the analog,
the observed inaccessibility of I30 is unexpected and should
originate from the involvement of this residue in an oligomeric
interface.
MD simulation provides a view of the potential dimer supporting the hypothesis of strand β2 as the dimer interface, with
E28, Q29, and I30 involved in the dimer interface when binding
on pure POPG lipid bilayer (Supplementary Fig. 8b). Our previous modeling study has suggested that, for hBD-3 analog with
the disulﬁde bonds released in reducing condition, the dimer
interfaces exhibit reduced stability in solution66, it thus becomes
important to understand how membrane interactions could
support oligomerization. Also, the NMR results support the
presence of oligomerized hBD-3 analogs in POPC/POPG bilayers,
but the exact oligomeric number remains unclear and awaits
experimental determination.
In conclusion, this study provides theretofore unavailable
experimental, molecular-level evidence for understanding the
functional structure and mechanism of β-defensin family. With
corroborated observations from spectroscopic and modeling
methods, we reveal that the peptide utilizes two highly conserved,
adjacent loops in the solution-NMR structure for membrane
partitioning. The secondary structural features and surface
charges may help the peptide to gain the energetically favorable
orientation to insert into and perturb the membrane. These novel
ﬁndings provide the structural basis for optimizing and developing defensin mimetics against pathogenic infections, and more
importantly, encourage many future investigations of the oligomerization state of defensins, their dependence on lipid
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composition, and the functional structure and mechanism of
many other relevant peptides and derivatives.
Methods
Peptide synthesis and puriﬁcation. The hBD-3 analog peptides of 45 amino acids
were synthesized using Fmoc chemistry. Two isotope-labeling schemes were used
to provide site-speciﬁc resolution and ensure coverage of the whole span of the
peptide sequence. The VALIG sample contains 13C, 15N-labeled residues V13, A19,
L21, I30, and G37, while IVLG sample contains 13C, 15N-labeled residues I3, V20,
L24, and G31. 13C,15N-labeled amino acids were protected by Fmoc in lab, with
purity of > 90% as monitored by 1H solution-NMR spectroscopy. The peptides
were synthesized using Fmoc solid-phase methods using 0.1 mM scale with ﬁvefold excess input for the labeled residues to ensure efﬁciency in the double couplings. The Fmoc group was then removed with 20% piperidine twice (3 min and
10 min) at room temperature, and the resin was washed with DMF and DCM. The
peptide was cleaved from the resin and sidechain deprotected using TFA/EDT/
water (4 mL, 94:3:3) for 5 hr. The cleavage reaction was repeated for 10 min. The
crude peptide was then puriﬁed by HPLC. Eluents for A is 0.1% TFA in water and
that for B is 0.1% TFA in acetonitrile. MALDI–TOF analysis was performed to
verify the molecular weight of peptides. In total, 5184.8 Da for VALIG and 5181.0
Da for IVLG are the match to the calculated molecular weight. The purity is higher
than 98% for both peptides.
Membrane-bound peptide sample preparation. Lipids 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol (POPG) at a molar ratio of 3:1 were dissolved in chloroform, and
dried using nitrogen gas to form a mixed lipid ﬁlm. The residual solvents were
completely removed under vacuum overnight. The lipid mixture powder was
resuspended in 10 mM HEPES buffer (pH 7.0). To prepare unilamellar vesicles, the
lipid mixture undergoes six cycles of freeze-thawing using 40 °C water bath and
liquid nitrogen. Simultaneously, the peptide solution is prepared by adding 400 µL
of HEPES buffer (10 mM, pH 7.0) to ~10 mg of the synthesized peptide. The
liposome solution and peptide solution were mixed, which results in precipitation
immediately, and this method has been used previously for preparing the hBD-3
analog-containing membranes for 2H ssNMR studies67. We chose a condensed
concentration of peptide, with a peptide-to-lipid molar ratio of 1:14, which converts to a mass ratio of 1: 2 to improve the population of peptides partitioning into
the membrane phase and ensure sufﬁcient NMR sensitivity. Since most peptides
remain dissolved and only a minor portion stays in the membrane, the actual
peptide-to-lipid ratio for the membrane-bound state should be well below 1:100.
The sample was spun down by centrifugation at 10000×g for 20 min. The supernatant was removed. The pellet was incubated in the desiccator overnight to slowly
remove the excess water, reduce the hydration to 65–70%, and packed into 4-mm
MAS rotors with a Kel-F insert.
Solid-state NMR experiments. All the solid-state NMR experiments were performed on a Bruker 400 MHz (9.4 Tesla) spectrometer. The radiofrequency ﬁeld
strengths are 71 kHz for 1H decoupling and 50–62.5 kHz for 13C. The 13C chemical
shifts were externally referenced to the TMS scale by calibrating the Met Cδ peak of
model peptide N-formyl-Met-Leu-Phe-OH (f-MLF)68 at 14.0 ppm. Most of the
spectra were collected under 10 kHz magic-angle spinning (MAS) at 298 K or 269
K. The typical recycle delays were 1.5–2.0 s.
To measure the 13C chemical shifts of hBD-3 analog, we measured a series of
2D 13C–13C Dipolar-Assisted Rotational Resonance (DARR) spectra with a
moderate mixing time of 100 ms69. At 298 K, DP using a 90° 13 C pulse with a short
recycle delay of 2 s was used to detect the mobile hBD-3 analogs in aqueous phase,
and CP was used to select the rigid, membrane-bound state. A moderately low
temperature of 269 K was chosen to partially immobilize peptides and enhance CP
sensitivity. This temperature was measured by a thermocouple that was a few
millimeters from the NMR rotor. Due to the heating effect of MAS, the real sample
temperature is estimated to be 2–5 °C higher. Because of the structural polymorph,
the coexistence of water and membrane phases, and the high solubility of hBD
peptides, the sensitivity becomes extremely challenging for CP-based experiments.
Despite the large amount of peptide (8 mg per sample), it still requires weeks of
NMR time (1920 scans) for measuring each 2D spectrum.
To determine the insertion depth, we measured 2D 13C-detected 1H spin
diffusion spectra at 269 K. By using a 1H T2 ﬁlter of 2 × 0.5 ms, the 1H
magnetization from mobile lipids and water was selected and then transferred to
peptides through a mixing period, and further to the 13C nuclei for site-speciﬁc
detection45,70. The semi-quantitative distances from peptide to water or lipid
chains are obtained by ﬁtting the buildup curves of peptide peak intensities as a
function of the square root of mixing times. All buildup curves were corrected by
T1 relaxation. The diffusion coefﬁcients for the lipid and peptide were DL of 0.012
nm2/ms, DW of 0.03 nm2/ms, respectively; the diffusion coefﬁcients for the sink
peptide was DP of 0.3 nm2/ms. For the lipid–peptide interface, DI as 0.00125 nm2/
ms for H2O and 0.0025 nm2/ms for CH2 were used. These values have been widely
used for antimicrobial peptides, DNA, and membrane channels44,45,71.
To probe the peptide dynamics, we conducted 13C–1H dipolar-chemical-shift
(DIPSHIFT) experiment72 at 269 K under 7.5 kHz MAS. Frequency-Switched
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Lee-Goldburg (FSLG) scheme73 was used for 1H homonuclear decoupling: the
transverse 1H ﬁeld strength is 83.3 kHz, converting to effective ﬁeld strengths of
102 kHz. The 13C π pulse is using a ﬁeld strength of 62.5 kHz. The number of t2
points is nine with an increment of 16.03 µs. Dipolar curves obtained by plotting
the peak intensity as a function of dipolar evolution time were then ﬁt using a
Fortran program to obtain the apparent CH or CH2 dipolar couplings. The rigidlimit dipolar coupling value is 22.7 kHz, which leads to the FSLG-scaled, rigid-limit
coupling value of 13.1 kHz (scaling factor 0.577). Order parameters are calculated
as the ratio between the measured couplings and the apparent rigid-limit value.
To examine the membrane morphology, we collected 1D and 2D 31P spectra for
POPC/POPG control sample and hBD-3-containing sample at 298 K. The 31P
chemical shift was referenced on the phosphoric acid scale. The control sample was
prepared as described above, but with two cycles of freeze-thawing using liquid
nitrogen and room-temperature water bath. In all 31P experiments, the
radiofrequency ﬁeld strength of 50 kHz for 31P was used with recycle delays of
1.5 s. Two-pulse phase-modulated (TPPM) decoupling sequence with 1H
decoupling ﬁeld strength of 50 kHz was used in both 1D static and MAS 31P
spectra. Under static condition, 1D 31P DP spectra were measured to probe lipid
orientation and membrane morphology. 2D static 31P–31P exchange spectra with
mixing times of 1, 5, 100, and 400 ms were measured to probe lipid lateral
diffusion50,51. 2D experiments were initiated from direct 31P polarization, and no
1H decoupling was used during the mixing period. 1D 31P DP and CP spectra were
also measured under slow MAS of 3.5 kHz to resolve the POPC and POPG signals,
and derive the 31P CSA parameters based on the spinning sideband intensities
using the Herzfeld–Berger analysis program53.
Circular dichroism measurement. To measure the circular dichroism (CD)
spectrum, both the solution state sample and membrane-bound state sample were
prepared. For the solution state sample, peptides were dissolved in HEPES buffer
(10 mM, pH 7.0) to reach a ﬁnal concentration of 0.3 mg/mL (57 μM). For the
membrane-bound state sample, POPC and POPG lipids at a molar ratio of 3:1 were
mixed, dried, and resuspended in the HEPES buffer (10 mM, pH 7.0) as described
above. The lipid mixture was treated with two freeze-thaw cycles in liquid nitrogen
and room-temperature water bath. The peptide sample was then added into the
liposome solution. The ﬁnal concentrations of total lipids and peptide are 1.74 mg/mL
and 0.3 mg/mL (57 μM), respectively. A lipid-only control sample was prepared with
the same protocol without adding the peptide.
CD spectra were measured at 293 K on a Jasco J-815 CD spectrometer using a
1-mm quartz cuvette. Each spectrum had three replicated scans. It was processed
through baseline correction, control sample subtraction, and smoothing
sequentially. The smoothing was carried out using the Savitsky-Golay smoothing
algorithm with the order of nine, The deconvolution of CD spectra was conducted
using the BestSel web server74.

simulation contains a dimer mixed with randomly packed 108 POPC and 36 POPG
lipids, 8425 TIP3P water molecules, and 42 SOD and 28 CLA ions spaciously
(Supplementary Fig. 8a). The initial box size is 211 × 212 × 256 Å, which allows
molecular rearrangement and assembly. After a brief energy minimization, the
simulation was conducted on an NPT ensemble using all-atom NAMD simulations
for 600 ns, the ﬁnal box is 103 × 61 × 76 Å.
Statistics and reproducibility. Two 13C,15N-labeled peptides and an unlabeled
peptide were measured. All attempts for replication were successful. All twodimensional experiments were carried out for 3–10 times and added together.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.

Data availability
The data that support the ﬁndings of this study are available from the corresponding
authors upon request. The data include solid-state NMR data (Bruker Topspin ﬁles) and
MD modeling ﬁles, which are currently stored in computers. The Source Data underlying
Figs. 2a, 2b, 3b–d, 4b, 4c, 6d, and 6e, as well as Supplementary Figs 4c, 4d, and 7 are
provided as Supplementary Data 1.
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